An Ecologically Valid, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Alzheimer Disease (the EVALUATE-AD Trial): Proof-of-Concept Study

BACKGROUND: The current clinical trial assessment methodology relies on a combination of self-report measures, cognitive and physical function tests, and biomarkers. This methodology is limited by recall bias and recency effects in self-reporting and by assessments that are brief, episodic, and clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Neil William Douglas, Beattie, Zachary, Marcoe, Jennifer, Wright, Kirsten, Sharma, Nicole, Mattek, Nora, Dodge, Hiroko, Wild, Katherine, Kaye, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287724/
https://www.ncbi.nlm.nih.gov/pubmed/32459184
http://dx.doi.org/10.2196/17603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287724/
https://www.ncbi.nlm.nih.gov/pubmed/32459184
http://dx.doi.org/10.2196/17603

Ejemplares similares